Literature DB >> 12966526

Left-sided CHILD syndrome caused by a nonsense mutation in the NSDHL gene.

Marybeth Hummel1, David Cunningham, Charles J Mullett, Richard I Kelley, Gail E Herman.   

Abstract

Congenital hemidysplasia with ichthyosiform nevus and limb defects (CHILD) syndrome is a rare X-linked dominant malformation syndrome characterized by unilaterally distributed ichthyosiform nevi, often sharply delimited at the midline, and ipsilateral limb defects. At least two-thirds of cases demonstrate involvement of the right side. Mutations in an essential enzyme of cholesterol biosynthesis, NAD(P)H steroid dehydrogenase-like [NSDHL], have been reported in five unrelated patients with right-sided CHILD syndrome and in a sixth patient with bilaterally, symmetric nevi and mild skeletal anomalies, but not with CHILD syndrome as originally defined. Although all of the molecularly diagnosed cases with the CHILD phenotype to date have had right-sided disease, we report here a novel nonsense mutation (E151X) of NSDHL in an infant with left-sided CHILD syndrome. This result demonstrates that both right- and left-sided CHILD syndrome can be caused by mutations in the same gene. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12966526     DOI: 10.1002/ajmg.a.20248

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

Review 1.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

Review 2.  Genodermatoses caused by genetic mosaicism.

Authors:  M Vreeburg; M A M van Steensel
Journal:  Eur J Pediatr       Date:  2012-11-01       Impact factor: 3.183

3.  Expression profile of NSDHL in human peripheral tissues.

Authors:  Marie Morimoto; Christèle du Souich; Joanne Trinh; Keith W McLarren; Cornelius F Boerkoel; Glenda Hendson
Journal:  J Mol Histol       Date:  2011-11-24       Impact factor: 2.611

4.  Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation.

Authors:  Anna Sukhanova; Andrey Gorin; Ilya G Serebriiskii; Linara Gabitova; Hui Zheng; Diana Restifo; Brian L Egleston; David Cunningham; Tetyana Bagnyukova; Hanqing Liu; Anna Nikonova; Gregory P Adams; Yan Zhou; Dong-Hua Yang; Ranee Mehra; Barbara Burtness; Kathy Q Cai; Andres Klein-Szanto; Lisa E Kratz; Richard I Kelley; Louis M Weiner; Gail E Herman; Erica A Golemis; Igor Astsaturov
Journal:  Cancer Discov       Date:  2012-11-02       Impact factor: 39.397

5.  Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR.

Authors:  Linara Gabitova; Diana Restifo; Andrey Gorin; Kunal Manocha; Elizabeth Handorf; Dong-Hua Yang; Kathy Q Cai; Andres J Klein-Szanto; David Cunningham; Lisa E Kratz; Gail E Herman; Erica A Golemis; Igor Astsaturov
Journal:  Cell Rep       Date:  2015-09-03       Impact factor: 9.423

6.  Pathogenesis-based therapy reverses cutaneous abnormalities in an inherited disorder of distal cholesterol metabolism.

Authors:  Amy S Paller; Maurice A M van Steensel; Marina Rodriguez-Martín; Jennifer Sorrell; Candrice Heath; Debra Crumrine; Michel van Geel; Antonio Noda Cabrera; Peter M Elias
Journal:  J Invest Dermatol       Date:  2011-07-14       Impact factor: 8.551

Review 7.  Lipoproteins, cholesterol homeostasis and cardiac health.

Authors:  Tyler F Daniels; Karen M Killinger; Jennifer J Michal; Raymond W Wright; Zhihua Jiang
Journal:  Int J Biol Sci       Date:  2009-06-29       Impact factor: 6.580

8.  A novel NSDHL variant in CHILD syndrome with gastrointestinal manifestations and localized skin involvement.

Authors:  Ene-Choo Tan; Shi Yun Chia; Khadijah Rafi'ee; Shan Xian Lee; Andrew Boon Eu Kwek; Sze Hwa Tan; Victor Weng Leong Ng; Heming Wei; Stephanie Koo; Ai Ling Koh; Mark Jean-Aan Koh
Journal:  Mol Genet Genomic Med       Date:  2021-12-26       Impact factor: 2.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.